SCHEMBL6256152

SCHEMBL6256152

[CH2]CC#CC#CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL302044 0.82
SCHEMBL8769739 0.82
SCHEMBL7667 0.79
SCHEMBL15641693 0.76
SCHEMBL5986850 0.76
SCHEMBL5986216 0.73
SCHEMBL10894658 0.73 HMGCR (0.48)
SCHEMBL5915241 0.71
SCHEMBL5985939 0.69
SCHEMBL2206246 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949575-B2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives PFIZER INC. (US) 2005-09-27 US disclosed
EP-1284958-B1 METHOD OF INHIBITING AMYLOID PROTEIN AGGREGATION AND IMAGING AMYLOID DEPOSITS USING AMINOIDANE DERIVATIVES WARNER LAMBERT CO (US) 2005-09-14 EP disclosed
US-20030220382-A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives BARTA NANCY SUE (US) 2003-11-27 US disclosed
EP-1284958-A1 METHOD OF INHIBITING AMYLOID PROTEIN AGGREGATION AND IMAGING AMYLOID DEPOSITS USING AMINOIDANE DERIVATIVES WARNER-LAMBERT COMPANY (US) 2003-02-26 EP disclosed
WO-2001083425-A1 METHOD OF INHIBITING AMYLOID PROTEIN AGGREGATION AND IMAGING AMYLOID DEPOSITS USING AMINOINDANE DERIVATIVES WARNER-LAMBERT COMPANY (US) 2001-11-08 WO disclosed